Wrapping dehydrated human amniotic membrane around nerve and anastomotic tissue during robotic prostatectomy was associated ...

The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy in men with intermediate-risk prostate cancer.

First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to ...

BRITISH surgeons say they have carried out remote robotic surgery for the first time. Paul Buxton, 62, had a prostate cancer ...

Profound Medical (PROF) announced superiority on the prespecified, primary safety endpoint in the Level 1 post-market CAPTAIN randomized controlled trial comparing the TULSA Procedure with robotic ...

King’s College London surgeon performs the UK’s first remote robotic surgery, pioneering telesurgery and transforming patient care ...

Hundreds of cancer patients in the region are to benefit from a new surgical robot thanks to a £1.45m donation from Sheffield ...

Profound Medical Corp. (NASDAQ:PROF) Q4 2025 Earnings Call Transcript March 6, 2026 Operator: Good day, and thank you for standing by. Welcome to the Profound Medical Fourth Quarter 2025 Financial ...

The PAUSE-URO study evaluated the safety of a new protocol for patients using direct oral anticoagulants (DOACs) prior to elective urologic surgery.

UK surgeons remotely removed a man’s prostate cancer from 1,500 miles away in the country’s first successful robot-assisted telesurgery.